Anthera Pharmaceuticals Inc Share Price Nasdaq
Equities
US03674U2015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from S&P TMI Index | CI |
2018 | Anthera Pharmaceuticals, Inc.(OTCPK:ANTH) dropped from NASDAQ Composite Index | CI |
Sales 2016 | 0.14 11.56 | Sales 2017 | - | Capitalization | 22.85M 1.82B |
---|---|---|---|---|---|
Net income 2016 | -55M -4.39B | Net income 2017 | -26M -2.07B | EV / Sales 2016 | 44,069,434 x |
Net cash position 2016 | 20.84M 1.66B | Net cash position 2017 | 2.2M 175M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 103B | |
+6.75% | 101B | |
+6.70% | 23.07B | |
-12.60% | 22.23B | |
-6.87% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |